Free tool · no signup
GLP-1 eligibility checker
Wondering if you meet the criteria for a GLP-1 weight-loss medication? Enter your height and weight for your BMI, and see how it maps to the thresholds studied for Wegovy and Zepbound — then talk to a clinician.
If you're starting GLP-1 therapy, GLPMate tracks your BMI, weight and doses from day one — free.
These matter at BMI 27–29.9, where a related condition is part of the criteria.
Enter your details to see how your BMI maps to the studied criteria.
The GLP-1 eligibility criteria
Weight-management GLP-1 medicines (Wegovy, Zepbound) were studied and labeled for adults who meet one of two BMI thresholds:
- BMI ≥ 30 (obesity), on its own; or
- BMI ≥ 27 (overweight) plus at least one weight-related condition — type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea or cardiovascular disease.
BMI is body weight (kg) divided by height (m) squared. In imperial units it's 703 × pounds ÷ inches². The World Health Organization categories: under 18.5 underweight, 18.5–24.9 normal, 25–29.9 overweight, 30+ obese.
Why BMI isn't the whole story
BMI can't tell muscle from fat, and thresholds differ for some populations. Insurers frequently add their own requirements — a documented history, a prior diet attempt, or a higher BMI. That's why this is a starting point for a clinician conversation, not a verdict.
Based on the FDA-labeled indications for semaglutide 2.4 mg (Wegovy) and tirzepatide (Zepbound) and WHO BMI categories. Educational only — not medical advice, not a diagnosis, and not a determination of eligibility. A licensed clinician decides.
This checker is for general education only. It does not determine eligibility, provide medical advice, diagnose any condition, or replace assessment by a licensed clinician. Eligibility for GLP-1 therapy is decided by your clinician and your insurer, based on your full medical history.
GLPMate is an independent tracking app — not a healthcare provider, prescriber or telehealth service. Wegovy® and Zepbound® are trademarks of their respective owners; GLPMate is not affiliated with or endorsed by them.
Eligibility questions
What BMI do you need to qualify for GLP-1 weight-loss medication?
The weight-management GLP-1s (Wegovy, Zepbound) were studied and labeled for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol or sleep apnea. This tool checks your BMI against those thresholds.
Is BMI the only thing that matters?
No. BMI is the starting screen, but real eligibility depends on your full medical history, your clinician's judgment and — often the deciding factor — your insurance criteria, which can be stricter. BMI also doesn't distinguish muscle from fat, so it's imperfect for very muscular or older bodies.
What about Ozempic and Mounjaro?
Ozempic and Mounjaro are approved for type 2 diabetes, with different criteria (a diabetes diagnosis, not a BMI threshold), though they contain the same drugs as Wegovy and Zepbound. This checker uses the weight-management BMI criteria. Your prescriber will match the right product to your situation.
My BMI is under 27 — is there any option?
Below BMI 27, weight-management GLP-1 is generally not indicated, and insurers won't usually cover it. That said, your clinician considers the whole picture. This tool can't and shouldn't make that call — it's a starting point for a conversation.
Does GLPMate prescribe or determine eligibility?
No. GLPMate is a tracking app, not a healthcare provider or telehealth service. This tool is educational and does not determine eligibility, provide medical advice, or replace an assessment by a licensed clinician.
Track from day one.
Free BMI & weight tracking. iOS & Android.